Nadia Dawn Ali MD (She/Her)

Associate Professor of Clinical Medicine, Director of the Comprehensive Sickle Cell Program, Penn Medicine, Hospital of the University of Pennsylvania

Join to view full profile

3401 N Broad StPhiladelphia, PA 19140
Phone+1 215-707-6356
Fax+1 215-707-3825

Dr. Ali is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ali's full profile Already have an account?

Summary

Dr. Nadia Ali is a hematologist based in Philadelphia, PA, specializing in sickle cell anemia and classical hematology. She completed her medical education at Southern Illinois University School of Clinical Medicine in 2011, followed by an internal medicine residency at Montefiore Medical Center and a hematology and medical oncology fellowship at Rutgers Robert Wood Johnson Hospital and the Cancer Institute of NJ in New Brunswick, NJ. She currently serves as an Associate Professor of Clinical Medicine in the Division of Hematology-Oncology at Penn Medicine. Prior to that she was with Temple University Hospital and Temple Physicians Inc. from 2017 to 2025. Her research is published in various journals, with notable works on sickle cell disease, reproductive technology considerations in hematologic patients, and venous thromboembolism experiences during the COVID-19 pandemic.

Education & Training

Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Gastroenterology, 2017 - 2023
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2017
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2011 - 2014
Southern Illinois University School of MedicineClass of 2011

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

PA State Medical License 2017 - 2026
NJ State Medical License 2015 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

"I Missed My Other Oncologist": Established Relationships as Barriers and Facilitators to Accessing CAR-T and Autologous Transplantation.
Zachary A K Frosch, Clark Meshack, Caitlin Meeker, Asya Varshavsky-Yanovsky, Rashmi Khanal
Cancer Medicine. 2025-12-01
Induced and spontaneous abortion outcomes among individuals with sickle cell disease.
Emma Braun, Kyler McVay, Nathanael Koelper, Nadia Ali, Kandace Gollomp
Contraception. 2025-12-01
2 citations
Special considerations in assisted reproductive technology for patients with hematologic disease.
Joshua Ewy, Suneeta Senapati, Nadia D Ali, Clarisa R Gracia
Fertility and Sterility. 2025-08-01

Press Mentions

Conference MDAngle: ASH 2024 Anemia and Red Blood Cell/Erythropoiesis-Related DisordersNovember 25th, 2024
Sickle Cell Anemia: What’s New and What’s NextMarch 27th, 2026